Squalene-based adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway

  1. Eui Ho Kim
  2. Matthew C Woodruff
  3. Lilit Grigoryan
  4. Barbara Maier
  5. Song Hee Lee
  6. Pratushya Mandal
  7. Mario Cortese
  8. Muktha S Natrajan
  9. Rajesh Ravindran
  10. Huailiang Ma
  11. Miriam Merad
  12. Alexander D Gitlin
  13. Edward S Mocarski
  14. Joshy Jacob
  15. Bali Pulendran  Is a corresponding author
  1. Emory University, United States
  2. Stanford University, United States
  3. Icahn School of Medicine at Mount Sinai, United States
  4. Genentech, United States

Abstract

The squalene-based oil-in-water emulsion (SE) vaccine adjuvant MF59 has been administered to more than 100 million people in more than 30 countries, in both seasonal and pandemic influenza vaccines. Despite its wide use and efficacy, its mechanisms of action remains unclear. In this study we demonstrate that immunization of mice with MF59 or its mimetic AddaVax (AV) plus soluble antigen results in robust antigen-specific antibody and CD8 T cell responses in lymph nodes and non-lymphoid tissues. Immunization triggered rapid RIPK3-kinase dependent necroptosis in the lymph node which peaked at 6 hours, followed by a sequential wave of apoptosis. Immunization with alum plus antigen did not induce RIPK3 kinase-dependent signaling. RIPK3-dependent signaling induced by MF59 or AV was essential for cross-presentation of antigen to CD8 T cells by Batf3-dependent CD8+ DCs. Consistent with this, RIPK3-kinase deficient or Batf3 deficient mice were impaired in their ability to mount adjuvant-enhanced CD8 T cell responses. However, CD8 T cell responses were unaffected in mice deficient in MLKL, a downstream mediator of necroptosis. Surprisingly, antibody responses were unaffected in RIPK3-kinase or Batf3 deficient mice. In contrast, antibody responses were impaired by in vivo administration of the pan-caspase inhibitor Z-VAD-FMK, but normal in caspase-1 deficient mice, suggesting a contribution from apoptotic caspases, in the induction of antibody responses. These results demonstrate that squalene-based vaccine adjuvants induce antigen-specific CD8 T cell and antibody responses, through RIPK3-dependent and-independent pathways, respectively.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Eui Ho Kim

    Emory Vaccine Center, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Matthew C Woodruff

    Medicine, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Lilit Grigoryan

    ITI, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Barbara Maier

    Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Song Hee Lee

    EVC, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Pratushya Mandal

    Microbiology and Immunology, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Mario Cortese

    ITI, Stanford University, Palo Alto, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Muktha S Natrajan

    Hope Clinic, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Rajesh Ravindran

    Yerkes, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Huailiang Ma

    ITI, Stanford University, Palo Alto, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Miriam Merad

    Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Alexander D Gitlin

    Physiological Chemistry, Genentech, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Edward S Mocarski

    Department of Microbiology and Immunology, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Joshy Jacob

    EVC, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Bali Pulendran

    ITI, Stanford University, Stanford, United States
    For correspondence
    bpulend@stanford.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6517-4333

Funding

National Institutes of Health (R37 DK057665)

  • Bali Pulendran

National Institutes of Health (R37 AI048638)

  • Bali Pulendran

National Institutes of Health (U19 AI057266)

  • Bali Pulendran

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#2002593) of Emory University.

Copyright

© 2020, Kim et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 7,686
    views
  • 1,013
    downloads
  • 56
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Eui Ho Kim
  2. Matthew C Woodruff
  3. Lilit Grigoryan
  4. Barbara Maier
  5. Song Hee Lee
  6. Pratushya Mandal
  7. Mario Cortese
  8. Muktha S Natrajan
  9. Rajesh Ravindran
  10. Huailiang Ma
  11. Miriam Merad
  12. Alexander D Gitlin
  13. Edward S Mocarski
  14. Joshy Jacob
  15. Bali Pulendran
(2020)
Squalene-based adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway
eLife 9:e52687.
https://doi.org/10.7554/eLife.52687

Share this article

https://doi.org/10.7554/eLife.52687

Further reading

    1. Immunology and Inflammation
    Matteo Napoli, Roland Immler ... Monika Pruenster
    Research Article

    S100A8/A9 is an endogenous alarmin secreted by myeloid cells during many acute and chronic inflammatory disorders. Despite increasing evidence of the proinflammatory effects of extracellular S100A8/A9, little is known about its intracellular function. Here, we show that cytosolic S100A8/A9 is indispensable for neutrophil post-arrest modifications during outside-in signaling under flow conditions in vitro and neutrophil recruitment in vivo, independent of its extracellular functions. Mechanistically, genetic deletion of S100A9 in mice caused dysregulated Ca2+ signatures in activated neutrophils resulting in reduced Ca2+ availability at the formed LFA-1/F-actin clusters with defective β2 integrin outside-in signaling during post-arrest modifications. Consequently, we observed impaired cytoskeletal rearrangement, cell polarization, and spreading, as well as cell protrusion formation in S100a9-/- compared to wildtype (WT) neutrophils, making S100a9-/- cells more susceptible to detach under flow, thereby preventing efficient neutrophil recruitment and extravasation into inflamed tissue.

    1. Computational and Systems Biology
    2. Immunology and Inflammation
    Lucia Csepregi, Kenneth Hoehn ... Sai T Reddy
    Research Article

    Diverse antibody repertoires spanning multiple lymphoid organs (i.e., bone marrow, spleen, lymph nodes) form the foundation of protective humoral immunity. Changes in their composition across lymphoid organs are a consequence of B-cell selection and migration events leading to a highly dynamic and unique physiological landscape of antibody repertoires upon antigenic challenge (e.g., vaccination). However, to what extent B cells encoding identical or similar antibody sequences (clones) are distributed across multiple lymphoid organs and how this is shaped by the strength of a humoral response remains largely unexplored. Here, we performed an in-depth systems analysis of antibody repertoires across multiple distinct lymphoid organs of immunized mice and discovered that organ-specific antibody repertoire features (i.e., germline V-gene usage and clonal expansion profiles) equilibrated upon a strong humoral response (multiple immunizations and high serum titers). This resulted in a surprisingly high degree of repertoire consolidation, characterized by highly connected and overlapping B-cell clones across multiple lymphoid organs. Finally, we revealed distinct physiological axes indicating clonal migrations and showed that antibody repertoire consolidation directly correlated with antigen specificity. Our study uncovered how a strong humoral response resulted in a more uniform but redundant physiological landscape of antibody repertoires, indicating that increases in antibody serum titers were a result of synergistic contributions from antigen-specific B-cell clones distributed across multiple lymphoid organs. Our findings provide valuable insights for the assessment and design of vaccine strategies.